4Fatih M.Uckun,Paul Gaynon,Harland Sather,et al.Clinical Features and Treatment Outcome of Children With Biphenotypic CD2+CD19+Acute Lymphoblastic Leukemia:A children's Cancer Group Study.Blood,1997,89(7):2488-2493.
5Lenormand B,Vannier JP,Bene MC,et al.The groupe D'Etude Immunologique Des Leucemies:CD2+CD19+ acute lymphoblastic leukemia in 16 children and adults:Clinicla and biological features.Br J Haematol,1993,83(4):580-588.
6Xue Yongquan，Int J Hematology，2000年，71卷，359页
7Drexler H G, Thiel E, Ludwig W D. Review of the incidence and clinical relevance of myeloid antigen positive acute lymphoblastic leukemia[J]. Leukemia, 1991, 5:637-645.
8Garand R, Bene M C, Faure, et al. Incidence, clinical and laboratory features and prognostic significance of immunophenotypic subgroups in acute lymphoblastic leukemia: the GEIL experience[J]. Recent Results Cancer Res, 1993, 131:283-295.
9Westbook C A, Hooberman A L, Spino C, et al. Clinical significance of the bcr-abl fusion gene in adult acult lymphoblastic leukemia: A cancer and leukemia group B study(8762)[J]. Blood, 1992, 80:2983.
10Thiebaut A, Vernant J P, Degos L. Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the french protocol LALA 87[J]. HematolOncol Cli North Am, 2000, 14(6):1353-1366.
